Essence Line has developed a biochip for early diagnosis of stroke
(ictus), which will enable targeted therapy applied in clinical
workplaces. The Agency for Business and Innovation (API) informed
that the company expects to improve the provision of health care to
patients with cerebrovascular disease after the implementation of
the concept. Essence Line used support from the Proof program
from Concept from OP PIK.
Source: ČIA NEWS, February 26th, 2021, www.cianews.cz/en
Compiled by the team of CzechTrade office in Riga.